Adjuvant nivolumab plus ipilimumab vs placebo for patients with localized renal cell carcinoma at high risk of relapse after nephrectomy: subgroup analyses from the phase 3 CheckMate 914 (part A) trial
| Title | Adjuvant nivolumab plus ipilimumab vs placebo for patients with localized renal cell carcinoma at high risk of relapse after nephrectomy: subgroup analyses from the phase 3 CheckMate 914 (part A) trial |
|---|---|
| Description | The abstract will be published at ASCO 2023. |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA010775 |
| Release Date | 2023-06-02 |
| Submitter | JIAN HUANG (hjgcp2017@163.com) |
| Organization | Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
| Submission Date | 2023-03-17 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX003385-01 | 914 Results_ASCO | 1 | Biomarker Data | 11.2 KB | rar | 0 | Controlled |